mTOR inhibitor
Catalog No. F17-901
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
F17-901-10 | 10 mg | $75 | |
F17-901-50 | 240 mg | $240 | |
F17-901-BULK | BULK | Contact Us |
Overview:
Potent immunosuppressant. The rapamycin-FKBP12 complex binds to and inhibits mTOR (1). Inhibits IL-2-induced activation of p70 S6 kinase (2). Extends lifespan of mice (3). Induces autophagy in a variety of cell lines (4).
References:
1. S Huang et al. Cancer Biol. Ther. 2003 2:222
2. CJ Kuo et al. Nature 1992 358:70
3. DE Harrison et al. Nature 2009 460:392
4. A Flemming et al. Nat. Chem. Biol. 2011 7:9
CAS Registry Number:
53123-88-9
Molecular Formula:
C51H79NO13
Appearance:
White crystalline powder
Melting Point:
N/A
Molecular Weight:
914.2
Purity:
>98% (TLC: 10% CH3OH in CH2Cl2; Rf=0.51); NMR (Conforms)
Solubilization:
Soluble in DMSO (50 mg/ml); or Ethanol (50 mg/ml)
Aliases:
Sirolimus; Fermentation product
Storage and Stability:
Storage, Stability and Shipping
Molecular Structure:
There are no related publications available for this product.
AKT/PKB Pathway, Angiogenesis, Apoptosis/Autophagy, Cancer, Inflammation, Metabolic Disorder
STAY CONNECTED
Fax: 1-604-232-4601